Fidelity Investments’s iBio IBIO Stock Holding History

Fidelity Investments’s Portfolio IBIO Stock Details IBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$757	Buy	+433	New	+$774	﹤0.01%	5271
2025 Q3	–	Sell	-1	Closed	-$1	–	5473
2025 Q2	$1	Buy	+1	New	+$1	﹤0.01%	5311
2025 Q1	–	Sell	-1	Closed	-$2	–	5492
2024 Q4	$2	Sell	1 -2	-67%	-$5	﹤0.01%	5504
2024 Q3	$6	Buy	+3	New	+$6	﹤0.01%	5451
2024 Q2	–	Sell	-4	Closed	-$16	–	5502
2024 Q1	$16	Buy	+4	New	+$5	﹤0.01%	5219
2023 Q4	–	Hold	0	–	-$2	–	5536
2023 Q3	–	Sell	-11	Closed	-$95	–	5247
2023 Q2	$129	Buy	+11	New	+$208	﹤0.01%	4939
2022 Q3	–	Sell	-5	Closed	-$1K	–	5139
2022 Q2	$1K	Sell	5 -2	-29%	-$301	﹤0.01%	4732
2022 Q1	$2K	Buy	+7	New	+$1.47K	﹤0.01%	4670
2021 Q4	–	Hold	0	–	–	–	4635
2021 Q3	–	Hold	0	–	–	–	4668
2021 Q2	–	Hold	0	–	–	–	4550
2020 Q2	–	Hold	0	–	–	–	3868
2020 Q1	–	Hold	0	–	–	–	3923

Other funds holding IBIO

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Fidelity Investments's IBIO Position: Q2 2026 in Review

Fidelity Investments opened a new position in iBio (IBIO) in Q2 2026: 433 shares worth $757. The stake represents ﹤0.01% of the portfolio and ranks #5271 among its holdings. This is a return to the name: Fidelity Investments previously reported a position in IBIO as recently as Q2 2025.

Fidelity Investments first reported a position in IBIO in Q1 2022 and has held it in 8 quarters since. The position peaked at $2K in Q1 2022. 55 funds tracked by Wall St. Rank hold IBIO as of Q2 2026.

Fidelity Investments held 433 shares of iBio worth $757 as of Q2 2026.
iBio was a new Fidelity Investments position in Q2 2026.
iBio made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #5271 holding.
Fidelity Investments first reported a position in iBio in Q1 2022 and has held it in 8 quarters since.
Fidelity Investments's iBio position peaked at $2K in Q1 2022.
55 funds tracked by Wall St. Rank held iBio as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.